№ files_lp_4_process_2_52236
File format: docx
Character count: 8887
File size: 95 KB
Educational chemistry text discussing the molecular properties and disinfectant mechanisms of ethanol and isopropyl alcohol in relation to recommended sanitizer concentrations and viral structure during the COVID-19 pandemic.
Topic:
Chemistry of disinfectants and alcohol-based sanitizers
Subject Area:
Chemistry; Public Health
Type of Document:
Educational explanatory text
Author:
Not specified
Institution / Organization Mentioned:
FDA (Food and Drug Administration)
Context:
COVID-19 pandemic
Key Substances Discussed:
Ethanol (ethyl alcohol); Isopropyl alcohol (isopropanol); Water
Related Viruses:
SARS-CoV-2; Influenza virus; Herpes virus; Rhinovirus; Norovirus; HIV
Scientific Concepts:
Enveloped viruses; Nonenveloped viruses; Hydrogen bonding; Protein coagulation; Molecular structure
Purpose:
Explanation of why different alcohol concentrations are used in hand sanitizers
Sources Referenced:
pediaa.com; byjus.com; cancer.gov; ehs.umich.edu; lumenlearning.com; clutchprep.com; fda.gov
Approximate Period:
COVID-19 pandemic era (2020s)
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / City:
United Kingdom
Subject:
Household cleaning product safety
Document Type:
Safety Data Sheet
Organization / Institution:
Thornton & Ross
Author:
Thornton & Ross
Target Audience:
General public, workers in chemical handling
Period of Validity:
Ongoing
Approval Date:
2021
Date of Changes:
None
Year:
2021
Region / City:
Canada
Topic:
Drug Submission Application
Document Type:
Fee Form
Institution:
Health Canada
Author:
Not specified
Target Audience:
Manufacturers, Sponsors
Period of Validity:
2021-2022
Approval Date:
Not specified
Amendment Date:
Not specified
Context:
Document providing details about application fees for drug submissions to Health Canada, including various categories and fee structures.
Year:
Month Year
Region / City:
Texas, USA
Subject:
Water quality and public health
Document Type:
Public notice
Agency:
Texas Commission on Environmental Quality (TCEQ)
Regulation Reference:
30 TAC §290.122
Contaminant:
Chlorine dioxide
Violation Type:
MRDL exceedance
Affected Population:
General public, infants, young children, pregnant women
Distribution System Monitoring:
Not completed
Notice Delivery:
Posted/Delivered within 24 hours and every 90 days until resolved
Year:
2026
Region / City:
Nairobi, Kenya
Topic:
Disinfectant and Antiseptic Safety
Document Type:
Safety Data Sheet
Organization / Institution:
SPECTRA CHEMICALS KENYA LIMITED
Manufacturer:
SPECTRA CHEMICALS KENYA LIMITED
Product Name:
Safi Kerol Disinfectant
Intended Use:
General-purpose disinfectant for home and farm use, sterilization of infective materials
Hazard Classification:
GHS Warning, Flammable, Eye and skin irritant
Precautionary Measures:
Eye and skin protection, avoid ingestion and inhalation
Storage Conditions:
Cool, well-ventilated area, away from sunlight and incompatible substances
Disposal Instructions:
Follow local regulations, recycling preferred
UN Hazard Class:
Class 6.1
Note:
Year
Type of Disinfectant:
Free chlorine / Chloramine
Minimum Residual:
0.2 mg/L for free chlorine, 0.5 mg/L for chloramine
Number of Customers:
Fewer than 750
Sampling Frequency:
Weekly for distribution system, monthly with coliform samples
Sample Count:
Up to 5 per worksheet
Data Recorded:
Sample date, sample site, disinfectant residual, below minimum, no residual
Reporting Form:
DLQOR
Purpose:
Monitoring disinfectant levels in small water systems
Year:
2023
Region / City:
Australia
Theme:
Medicine, Oncology
Document Type:
Submission Report
Organization / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Healthcare professionals, regulators
Period of Validity:
Ongoing
Approval Date:
28 March 2023
Modification Date:
December 2022
Year:
2018
Region / City:
Australia
Theme:
Pharmaceutical application
Document Type:
Authority Required listing submission
Agency / Organization:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Orphan Australia Pty Ltd
Target Audience:
Healthcare professionals, regulatory authorities
Effective Period:
Not specified
Approval Date:
12 June 2012
Amendment Date:
Not specified
Year:
2026-2027
Institution:
University of Santo Tomas
Department:
Research Center for Social Sciences and Education (RCSSED)
Document Type:
Research Proposal Form / Project Application
Academic Term:
First Term
Project Duration:
One Academic Year (August 2026 – May 2027)
Funding Source:
UST RCSSED and/or external sources
Proponent Information:
Name, Degree, Affiliation, Academic Rank, Research Interest Group (as applicable)
Collaborators:
Names and Affiliations (if any)
Expected Outputs:
Terminal Report, Journal Article, Book Chapter, Policy Brief, Other
Research Focus:
Alignment with Sustainable Development Goals (SDGs)
Approval and Endorsement:
Dean/Director, Director of RCSSED, Vice Rector for Research and Innovation
Year:
2024
Region / city:
Australia
Topic:
Pharmacological treatment
Document type:
Pharmaceutical submission
Agency / institution:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Unknown
Target audience:
Medical practitioners, healthcare professionals
Period of validity:
Not specified
Approval date:
23 December 2024
Date of amendments:
Not specified
Year:
2021
Region / City:
Australia
Topic:
Pharmaceutical submission
Document type:
Submission report
Organization:
Novartis Pharmaceuticals Australia Pty Limited
Author:
Novartis Pharmaceuticals Australia Pty Limited
Target audience:
Healthcare professionals, regulatory bodies
Period of validity:
Ongoing
Approval date:
21 August 2002
Date of revisions:
18 December 2009, 11 March 2016, 8 July 2021, 16 July 2021, 29 July 2021
Note:
Contextual description
Year:
2023
Region / city:
Australia
Subject:
Medical treatment
Document Type:
Submission for drug listing approval
Organization:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
VIFOR PHARMA PTY LIMITED
Target audience:
Healthcare professionals, regulatory bodies
Period of validity:
N/A
Approval date:
17 January 2023
Date of changes:
N/A
Context:
The document is a pharmaceutical submission for the inclusion of avacopan on the Pharmaceutical Benefits Scheme (PBS) for the treatment of severe active granulomatosis with polyangiitis and severe active microscopic polyangiitis in combination with other medications.
Year:
2023
Region:
Wales
Country:
United Kingdom
Healthcare system:
NHS Wales
Document type:
Patient Group Direction
Medicine:
Fluconazole 150 mg capsule
Clinical indication:
Vulvovaginal candidiasis
Service framework:
Clinical Community Pharmacy Service
Service component:
Common Ailment Service
Authoring body:
Welsh Medicines Advice Service
Approving body:
Community Pharmacy Clinical Advisory Group
Target professionals:
Registered community pharmacists
Legal basis:
Human Medicines Regulations 2012
Operational start date:
1 July 2023
Review date:
31 March 2026
Expiry date:
30 June 2026
Version:
1.0
Approval date:
3 July 2023
Source type:
Regulatory and clinical governance document
Year:
2026
Region / City:
United Kingdom
Topic:
Eating Disorders, Binge Eating, Bulimia
Document Type:
Workshop Material
Organization:
New Maudsley Skills
Author:
Not specified
Target Audience:
Carers, Families affected by eating disorders
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
N/A
Region / City:
N/A
Subject:
Phenolic compounds, Polyphenol analysis
Document Type:
Research data
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Researchers, scientists
Period of validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Contextual description:
Research data on the identification of phenolic compounds in pomegranate extract using LC-MS analysis.
Year:
2021
Region / city:
Australia
Topic:
Medical treatment, pharmaceuticals
Document type:
Submission for Authority Required listing
Organization / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
PBAC
Target audience:
Healthcare professionals, regulatory bodies
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
July 2021
Year:
2021
Region / City:
Australia
Subject:
Pharmaceutical submission
Document Type:
Submission for listing
Organization / Institution:
Astellas Pharma Australia Pty Ltd
Author:
Astellas Pharma Australia Pty Ltd
Target Audience:
Medical practitioners, regulatory bodies
Effective Period:
Since April 2021
Approval Date:
Not specified
Amendment Date:
Not specified